Developing a device to accurately detect recent cannabis use from saliva
Advancement of a Point-of-Need (PoN) platform device for accurate and destigmatized detection of recent cannabis use
This study is testing a new, easy-to-use device called XALIVA® that can quickly and accurately measure THC levels in saliva, making it helpful for workplaces and public places to better understand cannabis use and promote safety.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ricovr Healthcare INC. NIH-funded |
| Lab location | 1 site (Princeton, United States) |
| Project ID | NIH-10759597 on NIH RePORTER |
What this research studies
This research aims to create a point-of-need device called XALIVA® that can accurately measure THC levels in saliva, helping to reduce the stigma associated with cannabis use. The device is designed to be user-friendly and requires no special training, making it suitable for various settings such as workplaces and public areas. By providing precise and sensitive detection of recent cannabis use, this device could improve monitoring processes and enhance public safety. The research will also explore innovative biosensor technology to ensure effective THC quantification.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who may be subject to cannabis use monitoring, such as those in workplaces or treatment programs for Cannabis Use Disorder.
Not a fit: Patients who do not use cannabis or are not involved in environments where cannabis use monitoring is relevant may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and stigma-free monitoring of cannabis use, benefiting individuals with Cannabis Use Disorder and improving public safety.
How similar studies have performed: Other research has shown promise in developing biosensor technologies for drug detection, suggesting that this approach could be effective.
Where this research is happening
Princeton, United States
- Ricovr Healthcare INC. — Princeton, United States (Active)
Researchers
- Principal investigator: Seimetz, Joseph — Ricovr Healthcare INC.
- Study coordinator: Seimetz, Joseph
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.